Nicox S.A. (ALCOX.PA)

EUR 0.23

(-0.43%)

Long Term Debt Summary of Nicox S.A.

  • Nicox S.A.'s latest annual long term debt in 2023 was 25.15 Million EUR , down -0.57% from previous year.
  • Nicox S.A.'s latest quarterly long term debt in 2023 FY was 25.15 Million EUR , down -0.57% from previous quarter.
  • Nicox S.A. reported annual long term debt of 25.29 Million EUR in 2022, up 19.55% from previous year.
  • Nicox S.A. reported annual long term debt of 21.16 Million EUR in 2021, up 57.57% from previous year.
  • Nicox S.A. reported quarterly long term debt of 25.15 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Nicox S.A. reported quarterly long term debt of 18.38 Million EUR for 2023 Q2, up 2.39% from previous quarter.

Annual Long Term Debt Chart of Nicox S.A. (2023 - 2019)

Historical Annual Long Term Debt of Nicox S.A. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 25.15 Million EUR -0.57%
2022 25.29 Million EUR 19.55%
2021 21.16 Million EUR 57.57%
2020 13.42 Million EUR 0.0%
2019 - EUR 0.0%

Peer Long Term Debt Comparison of Nicox S.A.

Name Long Term Debt Long Term Debt Difference
European Medical Solutions 12.71 Million EUR -97.806%
FERMENTALG 14.33 Million EUR -75.429%
argenx SE 15.35 Million EUR -63.821%
BioSenic S.A. 15.57 Million EUR -61.517%
Celyad Oncology SA 902 Thousand EUR -2688.581%
Hyloris Pharmaceuticals SA 344 Thousand EUR -7211.919%
Onward Medical N.V. 16.3 Million EUR -54.256%
Oxurion NV 117 Thousand EUR -21398.291%
PHAXIAM Therapeutics S.A. 7.03 Million EUR -257.795%
Financière de Tubize SA - EUR -Infinity%
UCB SA 2.87 Billion EUR 99.126%